宝莫股份(002476) - 2024 Q4 - 年度业绩预告

Financial Performance - The net profit attributable to shareholders is expected to be 44.10 million RMB, representing a year-on-year increase of 742.68% compared to 6.61 million RMB in the same period last year[3] - The net profit after deducting non-recurring gains and losses is projected to be 4.20 million RMB, a growth of 123.83% from a loss of 17.63 million RMB in the previous year[3] - Basic earnings per share are estimated at 0.0721 RMB, compared to 0.1080 RMB in the same period last year[3] - The increase in net profit is primarily driven by strong market performance in the chemical business, with sales volume rising compared to the previous year[6] Investment Income - The company recognized approximately 44.84 million RMB in investment income from the termination of an equity investment in a subsidiary during the reporting period[6] Financial Reporting - The financial data presented is preliminary and has not yet been audited by an external accounting firm[4] - The company plans to disclose the final financial data in the 2024 annual report[7] Risks - There are risks associated with the accuracy of confirmed receivables from equity transfer, which may be affected by the credit status of counterparties[7]